It is also available for prescription to long-term users as a form of opioid replacement therapy in the Netherlands, United Kingdom, Switzerland, Germany, and Denmark, alongside psycho-social care —in the same manner that methadone or buprenorphine are used in the United States or Canada—and a similar programme is being campaigned for by liberal political parties in Norway.